Smith & Nephew Plc - Company Profile
Powered by 
All the sales intelligence you need on Smith & Nephew Plc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Smith & Nephew Plc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Smith & Nephew Plc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Smith & Nephew Plc (Smith & Nephew) is a medical technology company that develops, manufactures, and markets medical devices for use in orthopedic reconstruction and trauma, sports medicine, ENT, and advanced wound management. Its products include hip, knee, and shoulder replacement systems, robotics-assisted and digital enabling solutions, advanced products and instruments to repair or remove soft tissue, wound dressings, advanced wound bio-actives, and advanced wound devices. The company offers its products to surgeons; nurses and nurse specialists; physicians and general practitioners; and purchasing professionals in hospitals and healthcare insurers through the brands Oasis, Opsite, Pico, Primapore, Profore, and Renasys, among others. The company markets products across Europe, the Americas, Asia Pacific, the Middle East, and Africa. Smith & Nephew is headquartered in Watford, Hertfordshire, the UK.
Headquarters
United Kingdom
Address
Building 5, Croxley Park, Hatters Lane, Watford, England, WD188YE
Website
www.smith-nephew.com
Telephone
44 192 3477100
No of Employees
16,988
Industry
Medical Equipment
Ticker Symbol & Exchange
SN. (LON)
Revenue (2024)
$6.2B
6.1%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
51.7%
(2024 vs 2023)
Market Cap*
$12.7B
Net Profit Margin (2024)
XYZ
43.0%
(2024 vs 2023)
* As of and is in US$
Smith & Nephew Plc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Orthopedic Reconstructive | AETOS |
| Anthem Total Knee System | Acticoat |
| Oxinium Oxidized Zirconium | CORI |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | New Products/Services | In June, the company introduced the next-generation LEAF Patient Monitoring System, a data-driven pressure injury prevention platform. |
| 2026 | New Products/Services | In March, the company announced the launch of Allevyn Complete Care Foam Dressing, designed for wound management and pressure injury prevention. |
| 2026 | Contracts/Agreements | In February, the company entered into a distribution agreement with RMR Ortho to add the A’TOMIC Nitinol Fixation System to the company's trauma, foot & ankle and hand & wrist portfolio. |
Competitor Comparison
| Key Parameters | Smith & Nephew Plc | Stryker Corp | DePuy Synthes Inc | Solventum Corp | Zimmer Biomet Holdings Inc |
|---|---|---|---|---|---|
| Headquarters | United Kingdom | United States of America | United States of America | United States of America | United States of America |
| City | Watford | Portage | Warsaw | Eagan | Warsaw |
| State/Province | England | Michigan | Indiana | Minnesota | Indiana |
| No. of Employees | 16,988 | 56,000 | - | 20,000 | 17,000 |
| Entity Type | Public | Public | Private | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Rupert Christopher Soames | Chairman | Executive Board | 2023 | 67 |
| Deepak Nath | Chief Executive Officer; Director | Executive Board | 2022 | 54 |
| John Rogers | Director; Chief Financial Officer | Executive Board | 2024 | 58 |
| Ajay Dhankhar | Chief Strategy Officer; Chief Corporate Development Officer | Senior Management | 2025 | - |
| Alison Parkes | Chief Compliance Officer | Senior Management | 2022 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer